GPhA comes out tentatively in favor of risk-based FDA inspections; Lannett gets plant with Kremers buy;

> The Generic Pharmaceutical Association says it supports the FDA's plan to create quality metrics for companies and to do risk-based inspections but suggests the agency needs to phase them in to avoid drug shortages. Release

> Mundipharma is building a manufacturing plant in Singapore. Report

> Lannett has picked up a 300,000-square-foot manufacturing facility in Seymour, IN, as part of its $1.23 billion acquisition of Kremers Urban Pharmaceuticals, the specialty generic pharmaceuticals subsidiary of UCB. Release

> Packaging company Clariant will build a new plant in India to make pharma packaging. Report